Concepedia

Alia Thawer

AT

6

Publications

130

Citations

6

H-Index

2017

Active since

Affiliations

Sunnybrook Health Science Centre(Current)

Health Sciences Centre

Presbyterian Hospital

University of California, San Francisco

Stanford University

Alia Thawer is an author at Sunnybrook Health Science Centre specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2017–2022

6

Publications

6

Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review

David Chan, Emily K. Bergsland, Jennifer A. Chan et al. · The Oncologist · 2021 · 36 citations · Full text

Avelumab in unresectable/metastatic, progressive, grade 2–3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials

David Chan, Víctor Rodríguez-Freixinós, Mark Doherty et al. · European Journal of Cancer · 2022 · 32 citations

, , +7

Cancer Treatment During COVID-19: A Qualitative Analysis of Patient-Perceived Risks and Experiences with Virtual Care

Lesley Gotlib Conn, Houman Tahmasebi, Nicholas Meti et al. · Journal of Patient Experience · 2021 · 30 citations · Full text

, , +17

Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma

Jacques Raphael, Alia Thawer, Georg A. Bjarnason · Urologic Oncology Seminars and Original Investigations · 2017 · 12 citations

, , +6

Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review.

David Chan, Emily K. Bergsland, Jennifer A. Chan et al. · Journal of Clinical Oncology · 2019 · 10 citations

, , +19

Rows per page

1–5 of 6